JPWO2022131322A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022131322A5
JPWO2022131322A5 JP2022570052A JP2022570052A JPWO2022131322A5 JP WO2022131322 A5 JPWO2022131322 A5 JP WO2022131322A5 JP 2022570052 A JP2022570052 A JP 2022570052A JP 2022570052 A JP2022570052 A JP 2022570052A JP WO2022131322 A5 JPWO2022131322 A5 JP WO2022131322A5
Authority
JP
Japan
Prior art keywords
agent according
disease
neuronal
protein
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022570052A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022131322A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/046462 external-priority patent/WO2022131322A1/ja
Publication of JPWO2022131322A1 publication Critical patent/JPWO2022131322A1/ja
Publication of JPWO2022131322A5 publication Critical patent/JPWO2022131322A5/ja
Pending legal-status Critical Current

Links

JP2022570052A 2020-12-17 2021-12-16 Pending JPWO2022131322A1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020209492 2020-12-17
JP2020209568 2020-12-17
PCT/JP2021/046462 WO2022131322A1 (ja) 2020-12-17 2021-12-16 神経細胞賦活剤

Publications (2)

Publication Number Publication Date
JPWO2022131322A1 JPWO2022131322A1 (https=) 2022-06-23
JPWO2022131322A5 true JPWO2022131322A5 (https=) 2024-08-13

Family

ID=82059560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022570052A Pending JPWO2022131322A1 (https=) 2020-12-17 2021-12-16

Country Status (4)

Country Link
US (1) US20240033332A1 (https=)
EP (1) EP4265270A4 (https=)
JP (1) JPWO2022131322A1 (https=)
WO (1) WO2022131322A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414467B (zh) * 2022-10-14 2023-06-06 中国人民解放军陆军军医大学第二附属医院 载脂蛋白d在制备治疗脑出血药物中的用途
US20250157580A1 (en) * 2023-11-13 2025-05-15 Aspen Neuroscience, Inc. Methods of predicting dopamine production capability of differentiated neuronal cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0728732B2 (ja) * 1990-04-17 1995-04-05 日本石油株式会社 動物細胞増殖促進剤及び無血清培地
US7820439B2 (en) * 2003-09-03 2010-10-26 Reliance Life Sciences Pvt Ltd. In vitro generation of GABAergic neurons from pluripotent stem cells
JP5090645B2 (ja) * 2005-12-26 2012-12-05 政代 高橋 神経細胞移植補助剤および移植用神経細胞の製造法
WO2009089635A1 (en) * 2008-01-16 2009-07-23 Neurodyn, Inc. Treating neurodegenerative diseases with progranulin (pgrn)
JP5656482B2 (ja) * 2010-07-02 2015-01-21 森永乳業株式会社 統合失調症の陽性症状のための治療薬
JP2012165660A (ja) * 2011-02-10 2012-09-06 Kazuo Todokoro ヒト造血幹細胞を増幅させるための組成物及び方法
JPWO2015046574A1 (ja) * 2013-09-30 2017-03-09 国立大学法人 新潟大学 虚血後の再灌流に起因する出血を予防するための薬剤
US20180243343A1 (en) * 2015-02-26 2018-08-30 The Mclean Hospital Corporation Methods and compositions for the treatment or prevention of parkinson's disease
WO2017144443A1 (en) * 2016-02-22 2017-08-31 Newtricious B.V. Composition for the prevention or treatment of neurodegenerative diseases.
WO2020160458A1 (en) * 2019-02-01 2020-08-06 Avrobio, Inc. Compositions and methods for treating neurocognitive disorders
BR112021015817A2 (pt) * 2019-02-22 2021-10-13 The Trustees Of The University Of Pennsylvania Vírus adeno-associado recombinante para tratamento de neurodegeneração com início na idade adulta associado a grn
MX2022004812A (es) * 2019-10-22 2023-02-23 Applied Genetic Tech Corporation Sistemas de virus adeno-asociados (aav) para el tratamiento de enfermedades o trastornos neurodegenerativos asociados a la progranulina.
US20230227847A1 (en) * 2020-05-27 2023-07-20 Universität Zürich Viral vectors expressing therapeutic proteins specifically in myeloid cells and microglia
CN116324408A (zh) * 2020-06-18 2023-06-23 J·伦德奎斯特 分泌α-突触核蛋白靶向抗体、颗粒蛋白前体和鞘脂激活蛋白原及两者的复合物以及GDNF的细胞系
BR112023002374A2 (pt) * 2020-08-12 2023-03-21 UCB Biopharma SRL Terapia genética usando construções de ácido nucléico compreendendo sequências promotoras de proteína 2 de ligação de metil cpg (mecp2)

Similar Documents

Publication Publication Date Title
JPWO2022131322A5 (https=)
Quinn et al. Isolation and identification of homeobox genes from the human placenta including a novel member of the Distal-less family, DLX4
SI2860251T1 (en) Aptameric therapeutics useful in the treatment of complement-related disorders
Osumi The role of Pax6 in brain patterning
Iivonen et al. Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease
Apelt et al. Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques
DE69842099D1 (de) 5' ESTs für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
Perry et al. A metabolic basis for Alzheimer disease
Anisimov Serial Analysis of Gene Expression (SAGE): 13 years of application in research
Yoshida et al. Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells
EP2314310A3 (de) Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und- therapie
DE69835777D1 (de) 5' EST's für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
Sahoo et al. Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene
WO2001098491A3 (en) Osteolevin gene polymorphisms
EP2392593A3 (de) Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
Jing et al. The role of PGRN in Alzheimer’s disease
CA2320220A1 (en) Isolated dna or gene responsible for parkinson's disease
Small The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?
Dorszewska et al. Mutations of TP53 gene and oxidative stress in Alzheimer’s disease patients
WO2005019474A3 (en) Human autism susceptibility gene and uses thereof
Saarela et al. Interaction between matrix metalloproteinase 3 and the ε4 allele of apolipoprotein E increases the risk of Alzheimer’s disease in Finns
CA2283535A1 (en) Glycine transporter
JP2005517449A5 (https=)
Hiwatashi et al. Tissue-specific localization of mRNA for carrot homeobox genes, CHBs, in carrot somatic embryos
Nicoletti et al. No evidence of association between the alpha-2 macroglobulin gene and Parkinson's disease in a case–control sample